Hockey Hall of Famer spreading awareness on heart condition that forced him into early retirement [FOX News]
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (KNSA)
Last kiniksa pharmaceuticals, ltd. - class a ordinary shares earnings: 8/12 04:02 pm
Check Earnings Report
Company Research
Source: FOX News
In late 2020, Henrik Lundqvist had some gas left in the tank and was all set to put on an unfamiliar hockey sweater to extend his career just a bit longer. After spending 15 seasons with the New York Rangers , "King Hank" signed a one-year deal with the Washington Capitals ahead of the 2020-2021 season. But with a month left until the season began, Lundqvist had open-heart surgery in January 2021 due to a leaky aortic valve. Lundqvist returned to practice a month later, but the surgery did not cure his heart issues. While getting ready for his on-ice return with the Caps, Lundqvist had "flare-ups" in his heart. Ultimately, he was diagnosed with recurrent pericarditis, which left him in "a lot of pain" that was "affecting my everyday life." Knowing the risks, he decided to call it a career. "It definitely didn't end the way I planned it to. … It's a big day when you make that decision," Lundqvist told Fox News Digital in a recent interview about his decision to hang up the p
Show less
Read more
Impact Snapshot
Event Time:
KNSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNSA alerts
High impacting Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
KNSA
News
- New York Rangers Legend Henrik Lundqvist Signs On For ‘Life DisRPted' Campaign [Forbes]Forbes
- US Rheumatologists Identify BAFF-R Inhibitors as the Most Promising Treatment Approach for Sjögren's Disease, According to Spherix Global Insights [Yahoo! Finance]Yahoo! Finance
- NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent PericarditisGlobeNewswire
- Kiniksa Pharmaceuticals (KNSA) is on the Move, Here's Why the Trend Could be Sustainable [Yahoo! Finance]Yahoo! Finance
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $40.00 price target on the stock.MarketBeat
KNSA
Earnings
- 7/23/24 - Beat
KNSA
Sec Filings
- 9/25/24 - Form 4
- 9/23/24 - Form 144
- 9/4/24 - Form 4
- KNSA's page on the SEC website